Palisade Bio
PALI
11 hedge funds and large institutions have $57.5K invested in Palisade Bio in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
4.97% less ownership
Funds ownership: 6.74% → 1.76% (-5%)
15% less funds holding
Funds holding: 13 → 11 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
71% less capital invested
Capital invested by funds: $201K → $57.5K (-$143K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.6K |
| 2 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$7.52K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$1.3K |
| 4 |
T
Transce3nd
Kyle,
Texas
|
+$716 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$98.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$27K |
| 3 |
MG
Marex Group
London,
|
-$24.3K |
| 4 |
HF
HRT Financial
New York
|
-$12K |
| 5 |
VF
Virtu Financial
New York
|
-$10K |
PALI Hedge Fund Activity: Q2 2025 in Review
11 institutional investors reported a position in Palisade Bio (PALI) for Q2 2025, worth a combined $57.5K — down 71% from $201K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PALI and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was XTX Topco, opening a new position worth an estimated $19.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $98.6K sold.
- 11 institutional investors held Palisade Bio (PALI) as of Q2 2025, down from 13 in Q1 2025.
- Funds reported $57.5K of Palisade Bio stock for Q2 2025, down 71% quarter-over-quarter.
- 3 funds opened new Palisade Bio positions in Q2 2025 and 5 closed out, a net change of -2 holders.
- The largest Palisade Bio buyer in Q2 2025 was XTX Topco, an estimated $19.6K added.
- The largest Palisade Bio seller in Q2 2025 was Armistice Capital, an estimated $98.6K sold.
Based on aggregated 13F filings for Q2 2025.